Important Notice: Tirzepatide Compounding Update
We regret to inform you that the FDA has recently restricted the compounding of Tirzepatide for weight loss purposes. Due to this regulatory decision, we cannot accept new clients seeking weight loss treatment with Tirzepatide until further notification from regulatory authorities.
Tirzepatide, a medication known for its efficacy in managing weight, has been subject to regulatory scrutiny, prompting this temporary halt in its compounding for weight loss. We are closely monitoring FDA updates and will adjust our services accordingly based on official guidance.
For more information on this regulatory update, please refer to the FDA’s official statement:
FDA's official statementWe appreciate your understanding and patience as we navigate this regulatory adjustment. Please get in touch with us directly with any questions or concerns regarding your treatment plan.
